PRAXIS INVESTMENT MANAGEMENT INC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1056825
GOSHEN, IN
Position in PTGX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$235,843
-$81,407 QoQ
Shares Held
1,924
-72.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#256
of 341 holders
Holding Since
Sep 2024
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRAXIS INVESTMENT MANAGEMENT INC holds $15,079,585 across 30 Biotechnology names. PTGX ranks #25 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,269 | $2,617,270 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
6,152 | $1,152,146 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,970 | $894,059 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,310 | $816,837 | |
| 5 | INCY |
Incyte Corp
|
6,840 | $775,382 | |
| 6 | MRNA |
Moderna, Inc.
|
10,929 | $765,357 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
15,820 | $559,869 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
2,277 | $548,688 |
All Filings in PTGX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $235,843 | 1,924 | Shares | Sole | 2026-08-04 | |
| 2024-09-30 | $317,250 | 7,050 | Shares | Sole | 2024-10-21 | |
| No filing history on record for this holder in this stock. | ||||||